Safety and Efficacy of Caproamin Fides and Tranexamic Acid Versus Placebo in Patients Undergoing Coronary Artery Revascularization

@article{AlizadehGhavidel2014SafetyAE,
  title={Safety and Efficacy of Caproamin Fides and Tranexamic Acid Versus Placebo in Patients Undergoing Coronary Artery Revascularization},
  author={Alireza Alizadeh Ghavidel and Ziae Totonchi and Mitra Chitsazan and Maziar Gholampour dehaki and Farshid Jalili and Fariborz Farsad and Maral Hejrati},
  journal={Journal of Cardiovascular and Thoracic Research},
  year={2014},
  volume={6},
  pages={197 - 202}
}
Introduction: Excessive fibrinolysis contributes to post-cardiopulmonary bypass bleeding. Tranexamic Acid (TXA) and Caproamin Fides are synthetic lysine analogues that inhibit plasminogen-fibrin binding. The present study aimed to compare TXA and Caproamin Fides versus placebo in patients undergoing elective coronary artery revascularization. Methods: We analyzed perioperative data of 300 adult patients undergoing coronary artery revascularization. Patients were randomly allocated to receive… 
10 Citations

Figures and Tables from this paper

Different dose regimes and administration methods of tranexamic acid in cardiac surgery: a meta-analysis of randomized trials
TLDR
Low-dose intravenous infusion was the most preferable delivery method which was as effective as high-dose regimen in reducing transfusion rate without increasing the risk of seizure, and TXA was effective in reduced transfusion requirement in all kinds of cardiac surgeries.
The safety and efficiency of intravenous administration of tranexamic acid in coronary artery bypass grafting (CABG): a meta-analysis of 28 randomized controlled trials
TLDR
TXA is effective to reduce reoperation for bleeding, blood loss and the need for allogeneic blood products in patients undergoing CABG without increasing prothrombotic complication, however, it may increase the risk of postoperative seizures.
Tranexamic acid for the prevention and treatment of bleeding in surgery, trauma and bleeding disorders: a narrative review
TLDR
There is moderate evidence that TXA is effective for reducing bleeding in patients with menorrhagia, but some trials reported an increased rate of thrombotic complications with the use of TXA for gastro-intestinal bleeding and trauma.
Efficacy of TachoSil, a Fibrin-Based Hemostat, for Anterior Lumbar Spine Surgery
TLDR
The use of TachoSil is recommended for vessel injuries that vascular surgeons cannot suture or repair during ALF surgery, including the common iliac vein in 2 patients and a branch of a segmental artery from the aorta in 4 patients.
Exclusion criteria and adverse events in perioperative trials of tranexamic acid: a systematic review and meta‐analysis
TLDR
This study determined patient groups for whom safety information regarding TXA is lacking due to common exclusion from perioperative TXA trials are determined.
Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016.
TLDR
This update includes revisions to existing recommendations with respect to the wording, or changes in the grade of recommendation, and also the addition of new recommendations.
Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology.
TLDR
These guidelines are intended to provide an overview of current knowledge on the subject with an assessment of the quality of the evidence in order to allow anaesthetists throughout Europe to integrate this knowledge into daily patient care wherever possible.
STS/SCA/AmSECT/SABM Update to the Clinical Practice Guidelines on Patient Blood Management.
Department of Cardiovascular Surgery, Yavapai Regional Medical Center, Prescott, Arizona; Division of Cardiac Surgery, Libin Cardiovascular Institute, Foothills Medical Center, University of Calgary,
TRF_15030 806..824
  • 2019

References

SHOWING 1-10 OF 15 REFERENCES
Efficacy and Safety of Tranexamic Acid Versus ϵ-Aminocaproic Acid in Cardiovascular Surgery
TLDR
Considering the substantial cost difference and comparable efficacy and safety, ϵACA may have better value over TXA for reducing cardiovascular surgical bleeding.
Comparison of epsilon aminocaproic acid and tranexamic Acid in thoracic aortic surgery: clinical efficacy and safety.
TLDR
Both EACA and TXA were equally effective in reducing the perioperative blood loss and transfusion requirement in patients undergoing thoracic aortic surgery and there was a tendency for higher incidence of seizure with TXA.
Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery.
  • K. Martin, T. Breuer, G. Wiesner
  • Medicine
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
  • 2011
Meta-Analysis Comparing the Effectiveness and Adverse Outcomes of Antifibrinolytic Agents in Cardiac Surgery
TLDR
A meta-analysis to compare aprotinin, ϵ-aminocaproic acid, and tranexamic acid with placebo and head to head on 8 clinical outcomes found all antifibrinolytic agents were effective in reducing blood loss and transfusion.
The risk associated with aprotinin in cardiac surgery.
TLDR
The association between aprotinin and serious end-organ damage indicates that continued use is not prudent, and the less expensive generic medications aminocaproic acid and tranexamic acid are safe alternatives.
ε-Aminocaproic acid and clinical value in cardiac anesthesia.
TLDR
Considering the substantial difference in costs and with the increasing volume of high-risk cardiac surgery, EACA has increased "clinical value" when compared with TXA, and should be the antifibrinolytic medication of choice for high- risk cardiac surgery.
Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery.
TLDR
Findings indicate that in addition to the previously reported acute renal and vascular safety concerns, aprotinin use is associated with an increased risk of long-term mortality following CABG surgery.
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
TLDR
Data from the head-to-head trials suggest an advantage of aprotinin over the lysine analogues TXA and EACA in terms of reducing perioperative blood loss, but the differences were small.
Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients.
We simultaneously evaluated platelet and fibrinolytic parameters to assess their individual and combined contributions to postoperative blood loss in cardiopulmonary (CP) bypass patients. Platelet
Early reexploration for excessive postoperative bleeding lowers wound complication rates in open heart surgery.
TLDR
Sternal wound complications may be minimized by a policy of early re-exploration for excessive postoperative bleeding (greater than 200 ml/hr for 4 hours) in patients undergoing median sternotomy for open-heart surgery between 1979 and 1984.
...
1
2
...